Valproate inhibits the mitochondrial pyruvate‐driven oxidative phosphorylation in vitro
- 1 July 1997
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 20 (3) , 397-400
- https://doi.org/10.1023/a:1005398516208
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Studies on mitochondrial oxidative phosphorylation in permeabilized human skin fibroblasts: application to mitochondrial encephalomyopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Metabolism of valproate to hepatotoxic intermediatesInternational Journal of Clinical Pharmacy, 1992
- In vitro effects of valproate and valproate metabolites on mitochondrial oxidationsBiochemical Pharmacology, 1992
- In vitro effects of eight-carbon fatty acids on oxidations in rat liver mitochondriaBiochemical Pharmacology, 1990
- Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated ratsJournal of the Neurological Sciences, 1983
- Influence of valproic acid on hepatic carbohydrate and lipid metabolismArchives of Biochemistry and Biophysics, 1983
- Inhibitory effects of sodium valproate on oxidative phosphorylationNeurology, 1981
- [7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratiosPublished by Elsevier ,1967